Lindsay Robert M, Sternby Jan, Olde Bo, Persson Roland, Thatcher Mary Ellen, Sargent Kim
Optimal Dialysis Research Unit, London Health Sciences Centre, 800 Commissioners Road East, London, Ontario, Canada N6A 4G5.
Clin J Am Soc Nephrol. 2006 Sep;1(5):960-4. doi: 10.2215/CJN.00810306. Epub 2006 Jul 6.
Measurement of blood flow rate (Qa) is used to monitor arteriovenous fistulas and grafts that are used for hemodialysis blood access. Most Qa measurements use indicator dilution techniques to measure the recirculation that is induced by the reversal of hemodialysis blood lines. R plus the dialysis circuit flow (Qb) allows the calculation of Qa. The principle of needle reversal also can be used with a dialysate urea monitor (e.g., DQM 200 [Gambro]) without injection of diluent; the effect of the reversal on urea concentration is observed. Access blood water flow rate (Qaw) in relation to the effective clearance (K) is found from the urea concentrations in the dialysate with needles in the normal (Cn) and reverse (Cr) positions: K/Qaw = (Cn - Cr)/Cr. Qa is calculated by adjusting Qaw for hematocrit and protein. For testing of this theoretical relationship, 20 patients who were dialyzed on Integra (Hospal) and Centrysystem 3 (Cobe) machines that were fitted with DQM 200 were studied. During each treatment, lines were reversed and Qa was measured by ultrasound velocity dilution (Transonic HD01 monitor); at the same time, Cn and Cr were measured by DQM 200 and K was calculated. K1 was determined from a predialysis blood urea concentration (Cb), initial dialysate urea concentration (Cd), dialysate flow rate (Qd), and the relationship K x Cb = Qd x Cd (K1). K was determined separately from a conductivity step method using Diascan (Hospal) attached to Integra machines only (K2). With the use of K1, 127 comparisons were made; a correlation existed (r = 0.916), although Bland-Altman analysis showed that the dialysate urea method gave a mean value 5.3% +/- 15.3 (+/-SD) higher than that of Transonic (P < 0.001). With the use of K2, there also was a correlation of (r = 0.944; n = 63), and Bland-Altman testing showed an NS difference of +3.5% between the dialysate urea and Transonic methods. Qa can be estimated from on-line dialysate urea measurements that are taken before and after line reversal together with knowledge of K.
血流量(Qa)的测量用于监测用于血液透析血管通路的动静脉内瘘和移植物。大多数Qa测量采用指示剂稀释技术来测量因血液透析管路反转引起的再循环。R加上透析回路流量(Qb)可用于计算Qa。针反转原理也可与透析液尿素监测仪(如DQM 200[甘布罗公司])一起使用,无需注入稀释剂;观察反转对尿素浓度的影响。根据透析液中针处于正常(Cn)和反转(Cr)位置时的尿素浓度,可得出与有效清除率(K)相关的通路血液水流量(Qaw):K/Qaw = (Cn - Cr)/Cr。通过根据血细胞比容和蛋白质调整Qaw来计算Qa。为了验证这种理论关系,对20名在配备DQM 200的Integra(霍斯帕尔公司)和Centrysystem 3(科贝公司)机器上进行透析的患者进行了研究。在每次治疗期间,管路反转,通过超声速度稀释法(Transonic HD01监测仪)测量Qa;同时,用DQM 200测量Cn和Cr,并计算K。K1由透析前血尿素浓度(Cb)、初始透析液尿素浓度(Cd)、透析液流速(Qd)以及K x Cb = Qd x Cd(K1)的关系确定。仅在连接到Integra机器上时,使用Diascan(霍斯帕尔公司)通过电导率步进法单独确定K(K2)。使用K1时,进行了127次比较;存在相关性(r = 0.916),尽管布兰德-奥特曼分析表明,透析液尿素法得出的平均值比Transonic法高5.3% +/- 15.3(+/-标准差)(P < 0.001)。使用K2时,也存在相关性(r = 0.944;n = 63),布兰德-奥特曼测试表明透析液尿素法与Transonic法之间的差异无统计学意义,为+3.5%。Qa可根据管路反转前后在线测量的透析液尿素值以及K值进行估算。